Sun Pharmaceutical Industries Ltd (Sun Pharma) has received approval from the South African Health Products Regulatory Authority (SAHPRA) to manufacture and market a generic version of Semaglutide injection for the treatment of adults with inadequately controlled Type 2 diabetes mellitus. The approval marks South Africa as the second market after India where Sun Pharma has […]